Pyxis Oncology, Inc.
PYXS
$2.62
$0.020.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -47.33% | -47.34% | -42.88% | -32.86% | 6.40% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -23.00% | 107.33% | 70.22% | -15.53% | -24.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -16.55% | 0.00% | 0.00% | 0.00% | 10.57% |
| Total Current Assets | -45.56% | -44.20% | -37.93% | -35.10% | 6.29% |
|
|
|||||
| Total Current Assets | -45.56% | -44.20% | -37.93% | -35.10% | 6.29% |
| Net Property, Plant & Equipment | -12.31% | -11.95% | -12.27% | -11.03% | -10.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -100.00% | -89.69% | -89.49% | -89.28% | -89.30% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -41.77% | -45.93% | -40.87% | -38.30% | -9.52% |
|
|
|||||
| Total Accounts Payable | 124.02% | 100.33% | 72.07% | 24.12% | 24.72% |
| Total Accrued Expenses | -24.28% | -43.12% | -33.61% | -6.94% | -14.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.69% | 17.01% | 17.19% | 47.84% | 17.69% |
| Total Finance Division Other Current Liabilities | -32.97% | -- | -- | -- | -91.98% |
| Total Other Current Liabilities | -32.97% | -- | -- | -- | -91.98% |
| Total Current Liabilities | 19.52% | -4.62% | 4.62% | 2.04% | -31.36% |
|
|
|||||
| Total Current Liabilities | 19.52% | -4.62% | 4.62% | 2.04% | -31.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.43% | -8.90% | -8.40% | -7.21% | -6.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.62% | -11.54% | -7.83% | -9.15% | -24.14% |
|
|
|||||
| Common Stock & APIC | 2.56% | 2.59% | 2.94% | 2.97% | 17.55% |
| Retained Earnings | -21.90% | -29.60% | -31.39% | -32.90% | -27.02% |
| Treasury Stock & Other | -68.82% | -80.34% | 95.10% | 181.67% | 169.84% |
| Total Common Equity | -55.77% | -55.25% | -48.38% | -44.01% | -3.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.77% | -55.25% | -48.38% | -44.01% | -3.94% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.77% | -55.25% | -48.38% | -44.01% | -3.94% |
|
|
|||||